Tower Research Capital LLC (Trc) Bolt Biotherapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,688 shares of BOLT stock, worth $47,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,688
Previous 4,008
116.77%
Holding current value
$47,784
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding BOLT
# of Institutions
6Shares Held
706KCall Options Held
0Put Options Held
0-
Hawkeye Capital Management, LLC Miami Beach, FL415KShares$2.28 Million1.06% of portfolio
-
Black Rock Inc. New York, NY267KShares$1.47 Million0.0% of portfolio
-
Morgan Stanley New York, NY11.6KShares$63,8820.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ2.36KShares$12,9520.0% of portfolio
-
Jpmorgan Chase & CO New York, NY906Shares$4,9830.0% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $207M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...